Prevalence and correlates of antipsychotic polypharmacy: A systematic review and meta-regression of global and regional trends from the 1970s to 2009

被引:240
作者
Gallego, Juan A. [5 ]
Bonetti, John [2 ]
Zhang, Jianping
Kane, John M. [3 ,4 ,5 ]
Correll, Christoph U. [1 ,3 ,4 ,5 ]
机构
[1] Zucker Hillside Hosp, Ctr Translat Psychiat, Glen Oaks, NY 11004 USA
[2] Inst Living, Hartford, CT USA
[3] Albert Einstein Coll Med, Bronx, NY 10467 USA
[4] Hofstra N Shore LIJ Sch Med, Hempstead, NY USA
[5] Feinstein Inst Med Res, Manhasset, NY USA
基金
美国国家卫生研究院;
关键词
Combinations; Schizophrenia; Polypharmacy; Cotreatment; Meta-regression; INPATIENT SCHIZOPHRENIA CARE; PSYCHOTROPIC-DRUG USE; 4 EUROPEAN COUNTRIES; PRESCRIBING PATTERNS; CLINICAL-PRACTICE; ATYPICAL ANTIPSYCHOTICS; PSYCHIATRIC-PATIENTS; SCHIZOAFFECTIVE DISORDER; HOSPITAL INPATIENTS; CHINESE PATIENTS;
D O I
10.1016/j.schres.2012.03.018
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To assess the prevalence and correlates of antipsychotic polypharmacy (APP) across decades and regions. Methods: Electronic PubMed/Google Scholar search for studies reporting on APP, published from 1970 to 05/2009. Median rates and interquartile ranges (IQR) were calculated and compared using non-parametric tests. Demographic and clinical variables were tested as correlates of APP in bivariate and meta-regression analyses. Results: Across 147 studies (1,418,163 participants, 82.9% diagnosed with schizophrenia [IQR=42-100%]), the median APP rate was 19.6% (IQR=12.9-35.0%). Most common combinations included first-generation antipsychotics (FGAs) + second-generation antipsychotics (SGAs) (42.4%, IQR=0.0-71.4%) followed by FGAs + FGAs (19.6%, IQR=0.0-100%) and SGAs + SGAs (1.8%, IQR=0.0-28%). APP rates were not different between decades (1970-1979:28.8%, IQR=7.5-44%; 1980-1989:17.6%, IQR=10.8-38.2; 1990-1999:22.0%, IQR=11-40; 2000-2009:19.2% IQR=14.4-29.9, p=0.78), but between regions, being higher in Asia and Europe than North America, and in Asia than Oceania (p<0.001). APP increased numerically by 34% in North America from the 1980s 12.7%) to 2000s (17.0%) (p=0.94) and decreased significantly by 65% from 1980 (55.5%) to 2000 (19.2%) in Asia (p=0.03), with non-significant changes in Europe. APP was associated with inpatient status (p<0.001), use of FGAs (p<0.0001) and anticholinergics (<0.001), schizophrenia (p=0.01), less antidepressant use (p=0.02), greater LAIs use (p=0.04), shorter follow-up (p=0.001) and cross-sectional vs. longitudinal study design (p=0.03). In a meta-regression, inpatient status (p<0.0001), FGA use (0.046), and schizophrenia diagnosis (p=0.004) independently predicted APP (N=66, R-2=0.44, p<0.0001). Conclusions: APP is common with different rates and time trends by region over the last four decades. APP is associated with greater anticholinergic requirement, shorter observation time, greater illness severity and lower antidepressant use. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:18 / 28
页数:11
相关论文
共 176 条
[1]   Comparison of risperidone and olanzapine as used under "real-world" conditions in a state psychiatric hospital [J].
Advokat, C ;
Dixon, D ;
Schneider, J ;
Comaty, JE .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2004, 28 (03) :487-495
[2]   Classifying patients by antipsychotic adherence patterns using latent class analysis: Characteristics of nonadherent groups in the California Medicaid (Medi-Cal) program [J].
Ahn, Jeonghoon ;
McCombs, Jeffrey S. ;
Jung, Changun ;
Croudace, Tim J. ;
McDonnell, David ;
Ascher-Svanum, Haya ;
Edgell, Eric T. ;
Shi, Lizheng .
VALUE IN HEALTH, 2008, 11 (01) :48-56
[3]  
AMBUHL B, 1993, PSYCHIAT PRAX, V20, P70
[4]   Antipsychotic polypharmacy [J].
Ananth, J ;
Parameswaran, S ;
Gunatilake, S .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (18) :2231-2238
[5]   The prescribing pattern of a new antipsychotic: A descriptive study of aripiprazole for psychiatric in-patients [J].
Andersen, Stig Ejdrup ;
Johansson, Majka ;
Manniche, Charlotte .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 103 (01) :75-81
[6]   A COMPARISON OF INPATIENT AND OUTPATIENT PRESCRIBING [J].
ANDERSON, DN .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 :644-649
[7]  
[Anonymous], PRACTICAL META ANAL
[8]  
[Anonymous], 2002, Cochrane Database Syst Rev, DOI DOI 10.1002/14651858.CD001950
[9]  
BALDESSARINI RJ, 1995, AM J PSYCHIAT, V152, P1038
[10]   Clinical features and therapeutic management of patients admitted to Italian acute hospital psychiatric units: The PERSEO (psychiatric emergency study and epidemiology) survey [J].
Ballerini A. ;
Boccalon R.M. ;
Boncompagni G. ;
Casacchia M. ;
Margari F. ;
Minervini L. ;
Righi R. ;
Russo F. ;
Salteri A. ;
Frediani S. ;
Rossi A. ;
Scatigna M. ;
Barale F. ;
Bonzano A. ;
Scioli R. ;
Bellomo A. ;
De Giorgi A. ;
Cammeo C. ;
Cao A. ;
Zara B. ;
Conforti I. ;
Chillemi C. ;
Dagnino L. ;
Ponzoni M. ;
Della Pietra F. ;
Benettazzo M. ;
Esposito V. ;
Sposito M. ;
Fato M. ;
Signorello G. ;
Fiorenzoni S. ;
Singali A. ;
Margari F. ;
Sicolo M. ;
Martino C. ;
Leria G. ;
Tavoaccini L. ;
Nigro G. ;
Russo V. ;
La Roere R. ;
Righi R. ;
Mazzo M. ;
Rocchetti R. ;
De Martiis L. ;
Rodighiero S. ;
Morello M. ;
Vescera M. ;
Pisciotti D.G. ;
Villari V. ;
Barzegna G. .
Annals of General Psychiatry, 6 (1)